Paolo Lazzari

1-(2′,4′-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice

Livio Luongo, Enza Palazzo, Simone Tambaro et al. · Neurobiology of Disease · 2009 · 114 citations · Full text

Life Sciences, Neuroscience, Pharmacology +13

Tricyclic Pyrazoles. 4. Synthesis and Biological Evaluation of Analogues of the Robust and Selective CB₂Cannabinoid Ligand 1-(2‘,4‘-Dichlorophenyl)-6-methyl-<i>N</i>-piperidin-1-yl- 1,4-dihydroindeno[1,2-<i>c</i>]pyrazole-3-carboxamide

Gabriele Murineddu, Paolo Lazzari, Stefania Ruiu et al. · Journal of Medicinal Chemistry · 2006 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis

Maria Antonietta Casu, Andrea Mastinu, Paolo Lazzari · European Journal of Pharmacology · 2014 · 63 citations

Medicine, Immunology, Pharmacology +6

Tricyclic pyrazoles. Part 2: Synthesis and biological evaluation of novel 4,5-dihydro-1H-benzo[g]indazole-based ligands for cannabinoid receptors

Gabriele Murineddu, Stefania Ruiu, Jean‐Mario Mussinu et al. · Bioorganic & Medicinal Chemistry · 2005 · 49 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor antagonist compounds co-administration in female rats

Paolo Lazzari, Valeria Serra, S. Marcello et al. · European Neuropsychopharmacology · 2017 · 44 citations

Medicine, Neuroscience, Pharmacology +11